Thymogen

Thymogen (L-glutamyl-L-tryptophan) is a synthetic dipeptide that replicates key immunomodulatory activities of natural thymic hormones. Despite its minimal structure of only two amino acids, thymogen demonstrates significant effects on T-cell function, representing one of the smallest bioactive peptides in the immunomodulation field.

The compound was developed in Russia as a simplified, synthetic alternative to tissue-derived thymic extracts. Research identified that the Glu-Trp sequence represents a critical immunoactive motif that can stimulate T-lymphocyte maturation, enhance natural killer cell activity, and modulate cytokine production patterns toward improved immune competence.

Clinical applications in Russia have focused on supporting immune function in patients with chronic infections, immunodeficiency states, and as adjuvant therapy during chemotherapy or radiation treatment. Studies report improvements in T-cell counts, CD4/CD8 ratios, and resistance to opportunistic infections.

Thymogen's simple dipeptide structure offers significant practical advantages including ease of synthesis, defined composition, good stability, and potential for various administration routes including intranasal delivery. This distinguishes it from complex tissue extracts and larger thymic peptides that require more sophisticated manufacturing and handling.